Imipenem-Relebactam Susceptibility in Enterobacterales Isolates Recovered from ICU Patients from Spain and Portugal (SUPERIOR and STEP Studies)

Imipenem-relebactam is a novel β-lactam-β-lactamase inhibitor combination. We evaluated the in vitro activity of imipenem-relebactam and comparators against Enterobacterales clinical isolates recovered in 8 Spanish and 11 Portuguese intensive care units (ICUs) (SUPERIOR, 2016–2017; STEP, 2017–2018)....

Descripción completa

Detalles Bibliográficos
Autores principales: Hernández-García, Marta, García-Castillo, María, Bou, Germán, Cercenado, Emilia, Delgado-Valverde, Mercedes, Oliver, Antonio, Pitart, Cristina, Rodríguez-Lozano, Jesús, Tormo, Nuria, Melo-Cristino, José, Pinto, Margarida F., Gonçalves, Elsa, Alves, Valquíria, Vieira, Ana Raquel, Ramalheira, Elmano, Sancho, Luísa, Diogo, José, Ferreira, Rui, Cruz, Hugo, Chaves, Catarina, Duarte, Joana, Pássaro, Leonor, Díaz-Regañón, Jazmín, Cantón, Rafael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9602286/
https://www.ncbi.nlm.nih.gov/pubmed/36043877
http://dx.doi.org/10.1128/spectrum.02927-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9602286/
https://www.ncbi.nlm.nih.gov/pubmed/36043877
http://dx.doi.org/10.1128/spectrum.02927-22

Ejemplares similares